-
Nigericin: From Ion Gradients to Translational Strategy
2026-08-26
Nigericin is more than a catalog ionophore: it is a mechanistic probe for connecting potassium–proton exchange with intracellular pH, mitochondrial behavior, and GSDMD-linked cell fate. This thought-leadership perspective outlines how to validate those effects, interpret Nigericin anticancer activity responsibly, and use metabolic antibiotic research to define a broader but carefully bounded translational agenda.
-
Rocilinostat (ACY-1215) Research Workflows
2026-08-26
Rocilinostat (ACY-1215) enables selective HDAC6 target engagement studies, from α-tubulin acetylation and multiple myeloma cell viability assays to proteasome-inhibitor combination experiments. This guide also shows how to extend the compound cautiously into cilia and neural-progenitor research without conflating HDAC6 activity with the SMPD4–ceramide mechanism.
-
Measuring Drug Response in Cancer In Vitro
2026-08-25
Hannah Schwartz’s dissertation distinguishes relative viability from fractional viability, showing that growth inhibition and cell death are related but non-equivalent components of an anticancer response. This framework provides a practical basis for interpreting PARP inhibitor experiments, including breast cancer studies in which DNA repair pathway modulation may produce cytostatic, cytotoxic, or temporally separated effects.
-
Afatinib (BIBW 2992) in Gastric Assembloids
2026-08-25
Afatinib (BIBW 2992) offers translational researchers a mechanistically defined way to interrogate ErbB-driven signaling in patient-derived gastric cancer assembloids. By pairing irreversible EGFR, HER2, and HER4 inhibition with matched tumor–stroma models, researchers can move beyond simplified response estimates toward context-aware cancer biology research and targeted therapy research.
-
Carbapenemase Transmission in CREC in Guangdong
2026-08-24
Chen and colleagues characterize carbapenemase-encoding genes, their chromosomal or plasmid locations, and their transfer potential in carbapenem-resistant Enterobacter cloacae collected from eight Guangdong teaching hospitals. The study links blaNDM-1 dominance and frequent conjugative transfer with multidrug resistance, while ERIC-PCR reveals both widespread genetic diversity and possible clonal overlap across hospital settings.
-
Apicidin Disrupts Oocyte Quality and Histone Acetylation
2026-08-24
A 2026 study identifies a mechanistic link between Apicidin exposure, impaired oocyte meiotic maturation, cytoskeletal disruption, altered histone acetylation, DNA damage, and early apoptosis. Its findings extend the toxicological interpretation of this histone deacetylase inhibitor from somatic-cell effects to female germ-cell quality, while also defining important boundaries for in vitro reproductive-risk research.
-
Rocilinostat (ACY-1215): Selective HDAC6 Inhibitor
2026-08-23
Rocilinostat, also called ACY-1215, is a selective HDAC6 inhibitor with a reported biochemical IC50 of 5 nM. Preclinical multiple myeloma studies indicate that HDAC6 inhibition can increase tumor-cell stress and strengthen responses to proteasome inhibitors such as bortezomib.
-
Honokiol for In Vitro Drug Response Assays
2026-08-22
Honokiol helps researchers separate pathway modulation, growth arrest, and cell killing in cancer and inflammation models. This workflow pairs time-resolved viability measurements with NF-κB, oxidative-stress, and angiogenesis readouts for more interpretable in vitro results.
-
(S)-(+)-Ibuprofen: From COX Biology to Translation
2026-08-22
A mechanistic and strategic guide to using (S)-(+)-Ibuprofen as a defined COX inhibitor in inflammation pathway research, pain mechanism studies, and translational assay development.
-
Isradipine (Dynacirc) Research Workflows
2026-08-21
Isradipine (Dynacirc) provides a practical L-type calcium-channel perturbation for separating vascular and neuronal calcium responses. This guide combines formulation guidance, electrophysiology, excitotoxicity assays, hypertension research applications, and troubleshooting strategies.
-
Dinaciclib–VHL Synthetic Lethality in CC-RCC
2026-08-20
Nelson and colleagues identify a synthetic-lethal relationship between Dinaciclib treatment and VHL deficiency in clear cell renal cell carcinoma. Their complementary cell-based and orthotopic patient-derived xenograft experiments indicate that Dinaciclib suppresses tumor growth, induces apoptosis, and affects both cancer stem and non-stem cell populations while showing greater protection in nonmalignant or VHL-restored cells that are not actively dividing.
-
Sodium Orthovanadate for Signaling Assays
2026-08-20
Sodium Orthovanadate helps preserve phosphorylation-dependent signals in adipocyte lysates, kinase assays, and enzyme workflows. This guide combines practical Na3VO4 handling with assay-specific controls inspired by research on PI3K/AKT/GLUT4 insulin signaling.
-
Gamma-linolenic acid: Workflow & Applications
2026-08-19
Gamma-linolenic acid (GLA) supports reproducible studies of LTB4-linked inflammation, lipid signaling, and cell death. This practical guide combines receptor, cell-based, and translational workflows with resistance-surveillance lessons from a psychiatric hospital study.
-
HDAC Inhibition Reverses EBV-Driven NPC Plasticity
2026-08-19
The reference study identifies an epigenetic mechanism through which EBV protein LMP1 drives dedifferentiation and stem-like plasticity in nasopharyngeal carcinoma. It shows that HDAC inhibition can restore CEBPA expression and partially reverse this state in cellular and mouse xenograft models, supporting differentiation-based cancer therapy for selected solid tumors.
-
LNP Self-Replicating RNA Vaccine Storage: Key Evidence
2026-08-18
The reference study systematically examines how temperature, buffer composition, cryoprotection, and lyophilization affect lipid nanoparticle-formulated self-replicating RNA vaccines. Its central practical finding is that RNAse-free PBS containing 10% sucrose supported preservation of structure and in vivo potency at −20°C for 30 days, while lyophilization also retained bioactivity under the tested conditions.